Fee overview in AED: official fees versus practical estimate expenditure
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
When budgeting, official fees and practical estimate expenditure must be kept in two separate tables; mixing them into one table guarantees loss of control. The official fee items published on the EDE website are few: the medical device marketing authorisation application fee of AED 100, the medical device registration fee of AED 5,000, and the import permit application fee, also AED 100. Beyond these, the classification letter service fee, the manufacturing site registration fee and renewal fees that are often cited, as well as translation, notarisation and legalisation, agency services, warehousing and customs duty, are none of them statutory fees published by EDE; throughout this article they are labelled as practical estimate items.
- Official published fees: application fee AED 100, registration fee AED 5,000, import permit application fee AED 100.
- Classification letter, site registration and renewal amounts circulate as practical estimate figures, not official publications.
- Preparatory and follow-on spending, not the registration fee, usually dominates the budget.
- Customs duty moves linearly with cargo value and must be budgeted as a variable.
2. Legal basis
The fee figures below are taken from the current EDE service pages for marketing authorisation issuance, product classification and import permits, together with the decree provision that leaves further conditions to the executive regulation.
| Regulation | Reference | Publication | Provision | Key point |
| EDE service page: issuance of medical device marketing authorisation | Service page, no reference number | Currently published on the EDE website | Fees and conditions | Application fee AED 100 and medical device registration fee AED 5,000; the MAH and manufacturing site must first be registered |
| EDE service page: classification of medical products | Service page, no reference number | Currently published on the EDE website | Service content | Issues a classification letter confirming the regulatory category and whether a marketing authorisation is required |
| EDE service page: import permit for medical items and products | Service page, no reference number | Currently published on the EDE website | Fees and conditions | Import permit application fee AED 100; the permit is valid for 2 months from the date of issue |
| Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical Establishments | Federal Decree-Law No. 38/2024 | Issued 1 October 2024, effective 2 January 2025 | Article 6(1)(h) | Other conditions are set by the executive regulation; fee positions follow what EDE publishes |
3. Expert insights
Insight 1: official fees are verifiable fixed items; practical estimate items are the volatile ones. The AED 100 and AED 5,000 figures come straight from the EDE service pages and are fixed expenditures that can be verified item by item. The classification letter service fee of AED 500, the manufacturing site registration fee of approximately AED 10,100, and the renewal of AED 100 + AED 2,500 are practical estimate items whose source is prevailing industry practice rather than official publication. Our method is to keep two lines in the budget: one records the official positions with screenshots of the service pages retained in step, and one records practical estimate items with the date and source of each figure marked, allowing a wider floating band for the latter during internal approval.
Insight 2: what really moves the budget is usually not the registration fee but the preparatory and follow-on spending. Article 6(1)(f) requires a valid GMP certificate issued by EDE, by the competent authority of the country of origin or by a reference institution recognised by EDE, and Article 6(1)(c) requires the assembly of reference-country evidence; the preparatory cost of these two items is usually higher than the registration fee itself. Once embassy legalisation, Arabic translation, sample shipment, agency services and post-arrival warehousing and distribution are added, the share of official fees in the total budget is significantly diluted, and the budget table must list each of these stages on its own line.
Insight 3: customs duty and clearance costs must be calculated on cargo value, not on a fixed per-shipment budget. UAE customs duty levied at 5% of the CIF value is a practical estimate figure, moving linearly with cargo value and shipment batches. After multiple agents operate in parallel, declaration batches increase, and each batch also incurs declaration agency and inspection-related spending. We recommend turning customs duty and clearance costs into a rolling variable budget driven by shipment volume and folding them into the unit cost model, rather than entering them once into the project budget and never updating them.
4. Practical recommendations
- Build two fee tables: the official fee table maps item by item to the EDE service pages with screenshots retained, and the practical estimate table separately marks source and date for each figure.
- Account separately for the official review period of 45 working days and the preliminary site registration and dossier preparation cycles, so the duration of capital lock-up is not underestimated.
- Estimate all practical estimate items as ranges with float reserved; never plan funding on a single number, paying particular attention to legalisation and translation spending.
- Enter customs duty at 5% of CIF value (practical estimate) into the unit cost model, and update it on a rolling basis with exchange rates and freight rates.
- For products with one model and multiple specifications, assess model consolidation first before deciding whether to register specification by specification, avoiding paying the AED 5,000 registration fee repeatedly.
- Before payment, re-check the fee column of the EDE service page; where service fees are adjusted, the latest official publication governs.
5. Verification checklist
- □ The official fee table includes the application fee AED 100, registration fee AED 5,000 and import permit AED 100, with service page screenshots retained
- □ Practical estimate expenditure is labelled item by item as practical estimate with its source date marked
- □ The classification letter service fee AED 500 (practical estimate) is included in the preparatory budget
- □ The manufacturing site registration fee of approximately AED 10,100 (practical estimate) is listed as a separate line
- □ The renewal fee AED 100 + AED 2,500 (practical estimate) has a maturity reserve set aside
- □ Customs duty 5% (practical estimate, on CIF value) is built into the unit cost model
- □ Translation, notarisation and legalisation, sample shipment and agency service fees are listed item by item
- □ The model consolidation option has been assessed, avoiding repeated payment of the registration fee
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the United Arab Emirates. Our team coordinates local authorised representative and importer arrangements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us